Multi Symptom NiteTime Interactions
There are 467 drugs known to interact with Multi Symptom NiteTime (acetaminophen / dextromethorphan / doxylamine), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 89 are major, 362 are moderate, and 16 are minor.
- View all 467 medications that may interact with Multi Symptom NiteTime
- View Multi Symptom NiteTime alcohol/food interactions (2)
- View Multi Symptom NiteTime disease interactions (11)
Most frequently checked interactions
View interaction reports for Multi Symptom NiteTime (acetaminophen / dextromethorphan / doxylamine) and the medicines listed below.
- acetaminophen
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- azithromycin
- Benadryl (diphenhydramine)
- benzonatate
- cyclobenzaprine
- diphenhydramine
- docusate
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydroxychloroquine
- ibuprofen
- levothyroxine
- loratadine
- magnesium oxide
- melatonin
- metformin
- naproxen
- omeprazole
- ondansetron
- Pepto-Bismol (bismuth subsalicylate)
- prednisone
- ProAir HFA (albuterol)
- propranolol
- sertraline
- tramadol
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Multi Symptom NiteTime alcohol/food interactions
There are 2 alcohol/food interactions with Multi Symptom NiteTime (acetaminophen / dextromethorphan / doxylamine).
Multi Symptom NiteTime disease interactions
There are 11 disease interactions with Multi Symptom NiteTime (acetaminophen / dextromethorphan / doxylamine) which include:
- alcoholism
- liver disease
- depression
- PKU
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- resp depression
Report options
More about Multi Symptom NiteTime (acetaminophen / dextromethorphan / doxylamine)
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
